0000899243-20-031435.txt : 20201118 0000899243-20-031435.hdr.sgml : 20201118 20201118160011 ACCESSION NUMBER: 0000899243-20-031435 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201116 FILED AS OF DATE: 20201118 DATE AS OF CHANGE: 20201118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Le-Nguyen Quoc CENTRAL INDEX KEY: 0001792062 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 201324862 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 BUSINESS PHONE: 4155004614 MAIL ADDRESS: STREET 1: 535 MISSION STREET STREET 2: 14TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-11-16 0 0001785173 89bio, Inc. ETNB 0001792062 Le-Nguyen Quoc C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 0 1 0 0 See Remarks Common Stock 2020-11-16 4 M 0 4548 3.11 A 4548 D Common Stock 2020-11-16 4 S 0 4548 28.11 D 0 D Stock Option (Right to Buy) 3.11 2020-11-16 4 M 0 4548 0.00 D 2029-07-30 Common Stock 4548 21938 D This transaction was executed pursuant to a Rule 10b5-1 trading plan. This option represents a right to purchase a total of 26,486 shares of the Issuer's common stock, one quarter of which vested on July 23, 2020, with the remaining three quarters vesting in equal quarterly installments over the following three years. Chief Technical Operations Officer and Head of Quality /s/ Ryan A. Murr, as attorney-in-fact for Quoc Le-Nguyen 2020-11-18